Abstract
Background
Few studies have assessed racial/ethnic differences in survival after primary glioblastoma diagnosis. We investigate these differences, incorporating information on White, Hispanics and Asians, as well as White, non-Hispanics and Blacks, among elderly individuals with a primary glioblastoma utilizing the population-based Surveillance, Epidemiology and End Results (SEER) Program-Medicare linked database.
Methods
A total of 1,530 individuals diagnosed > = 66 years of age from 6/1/91 to 12/31/99 in the SEER data were linked with Medicare information from 1/1/91 to 12/31/01. All individuals had Medicare Parts A and B and were non-HMO for 6 months before and 12 months after diagnosis to gather pre-diagnosis co-morbidities and post-diagnosis first course of treatment. Survival differences by race/ethnicity and by race/ethnicity stratified by treatment type and/or median household income were examined using Kaplan–Meier and multivariable Cox proportional hazards models.
Results
Significant racial/ethnic differences existed between White, non-Hispanics and Blacks in marital status, income and SEER registry region for the entire US. In analysis limited to the West region, significant racial/ethnic differences existed for income only. Overall there were no differences in survival between White, non-Hispanics and Blacks, however, in analysis limited to the West region, Asians had a lower risk of death compared to White, non-Hispanics [HR = 0.67, 95% CI (0.43, 1.03)]. Asians who had multiple treatments also had a lower risk of death compared to White, non-Hispanics [HR = 0.65, 95% CI (0.41, 1.01)].
Conclusions
Racial/ethnic differences in survival after primary glioblastoma diagnosis exist and may be partially explained by racial/ethnic differences in treatment and income.
Similar content being viewed by others
References
Batchelor Tracy DMV, Hunter David J (2005) Epidemiology, pathology, and imaging of brain tumors. In: Peter M, Black JSL (eds) Cancer of the nervous system, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1–13
CBTRUS (2005) Statistical report: primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Chicago, IL
Greig NH, Ries LG, Yancik R, Rapoport SI (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82(20):1621–1624
Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977–2000. Cancer 101(10):2293–2299
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg 99(3):458–466
Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML (1999) The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85(2):485–491
Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncol 4:278–299
GLOBOCAN (2002) Worldwide incidence and mortality of cancer. International Agency for Research on Cancer (IARC), Lyon
Inskip PD, Linet MS, Heineman EF (1995) Etiology of brain tumors in adults. Epidemiol Rev 17(2):382–414
Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS et al (1999) Cancer surveillance series: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91(16):1382–1390
Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973–2001. Neurosurg Focus 20(4):E1
Fan KaP GH (1992) Ethnic distribution of primary central nervous system tumors in Washington, DC, 1971–1985. J Natl Med Assoc 84(10):858–863
Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin SA (2005) Population-based description of glioblastoma multiforme in Los Angeles county, 1974–1999. Cancer 104(12):2798–2806
Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16(6):562–566
Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG (1999) Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro-oncol 1(1):14–25
Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB (1990) Analysis of patterns of care of brain tumor patients in the United States: a study of the brain tumor section of the AANS and the CNS and the commission on cancer of the ACS. Clin Neurosurg 36:347–352
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98(3):603–609
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg 99(3):458–466
Claus EB, Black PM (2006) Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer 106(6):1358–1363
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al (2005) SEER cancer statistics review, 1975–2002. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975–2002
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV3–IV18
SEER (2005) Surveillance, Epidemiology and End Results (SEER) Program. seer.cancer.gov
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology, 3rd edn. (ICD-O-3)
United States Public Health Service (2003) International classification of diseases, 9th edn; Clinical modification, 6th edn. United States Public Health Service, Washington
American Medical Association (2000) Physician’s current procedural terminology (CPT) 2001, Professional edn. American Medical Association, Chicago
Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8 Suppl):IV26–IV35
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619
NCHS (2006) National Center for Health Statistics, geographic region and division definitions. http://www.cdc.gov/nchs/datawh/nchsdefs/region.htm
Klein J, Moeschberger ML (1997) Survival analysis: techniques for censored and truncated data. Springer, New York
SAS (2003) Statistical analysis software, version 9.1. SAS Institute Inc., Cary
Kelly PJ, Hunt C (1994) The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34(1):62–66; discussion 66–67
Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A et al (2003) A prospective study on glioblastoma in the elderly. Cancer 97(3):657–662
Keime-Guibert F, Chinot O, Tallandier L, Cartalat-Carel S, Frenay M, Kantor G et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535
Lowry JK, Snyder JJ, Lowry PW (1998) Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 55(7):922–928
Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G et al (2006) Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 76(2):159–163
Meckling S, Dold O, Forsyth PA, Brasher P, Hagen NA (1996) Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47(4):901–905
Pierga JY, Hoang-Xuan K, Feuvret L, Simon JM, Cornu P, Baillet F et al (1999) Treatment of malignant gliomas in the elderly. J Neurooncol 43(2):187–193
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98(3):603–609
Baily IC (1971) The pattern and presentation of intracranial tumors in Uganda. East Afr Med J 48:565–575
Fan KJ, Kovi J, Earle KM (1977) The ethnic distribution of primary central nervous system tumors: AFIP, 1958 to 1970. J Neuropathol Exp Neurol 36(1):41–49
Kasili EG, Cameron HM, Ruberti RF, Chopra SA (1973) Histopathology of brain tumours in the African in Kenya. Afr J Med Sci 4(2):99–106
Levy LF (1973) Brain tumours in Malawi, Rhodesia and Zambia. Afr J Med Sci 4(4):393–397
Manfredonia M (1973) Tumours of the nervous system in the African in Eritrea (Ethiopia). Afr J Med Sci 4(4):383–387
Odeku EL, Osuntokun BO, Adeloye A, Williams AO (1972) Tumors of the brain and its coverings. An African series. Int Surg 57(10):798–801
Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL et al (2001) Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res 61(10):3949–3954
Li Y, Millikan RC, Carozza S, Newman B, Liu E, Davis R et al (1998) p53 mutations in malignant gliomas. Cancer Epidemiol Biomarkers Prev 7(4):303–308
Mochizuki S, Iwadate Y, Namba H, Yoshida Y, Yamaura A, Sakiyama S et al (1999) Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients. Int J Oncol 15(5):983–989
Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R et al (2005) Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 14(7):1774–1783
Wiencke JK (2004) Opinion: impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer 4(1):79–84
Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB (1989) National survey of patterns of care for brain-tumor patients. J Neurosurg 71(6):826–836
Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG (1999) Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro-oncol 1(1):14–25
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996
Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB (2002) Survival of blacks and whites after a cancer diagnosis. JAMA 287(16):2106–2113
Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357
Ries LAG et al (2005) SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda
Acknowledgment
Supported for JSB-S by National Cancer Institute grant number K07 CA91849 and for AES by NCI grant number K08101954.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr Barnholtz-Sloan has now moved to a new institution, but this study was performed while she was at the H. Lee Moffitt Cancer Center and Research Institute
Rights and permissions
About this article
Cite this article
Barnholtz-Sloan, J.S., Maldonado, J.L., Williams, V.L. et al. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 85, 171–180 (2007). https://doi.org/10.1007/s11060-007-9405-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9405-4